MoneyWorks4Me

Ajanta Pharma reports Profit after tax of Rs 1348.40 Mln, in the March 2022 quarter

10 May 2022 Evaluate
The quarter ended March 2022 witnessed marginal change in the total revenue. The figure for the mentioned quarter is pegged at Rs. 7656.30 millions.Net profit declined -12.88% to Rs. 1348.40 millions from Rs. 1547.80 millions.Operating profit for the quarter ended March 2022 decreased to 2155.70 millions as compared to 2484.10 millions of corresponding quarter ended March 2021.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202203 202103 % Var 202203 202103 % Var 202203 202103 % Var
Sales 7656.30 7480.70 2.35 31406.40 27185.90 15.52 31406.40 27185.90 15.52
Other Income 284.20 13.30 2036.84 1397.30 1035.70 34.91 1397.30 1035.70 34.91
PBIDT 2155.70 2484.10 -13.22 10306.20 10204.80 0.99 10306.20 10204.80 0.99
Interest 71.80 21.80 229.36 91.20 69.00 32.17 91.20 69.00 32.17
PBDT 2083.90 2462.30 -15.37 10215.00 10135.80 0.78 10215.00 10135.80 0.78
Depreciation 300.90 294.80 2.07 1209.60 1114.90 8.49 1209.60 1114.90 8.49
PBT 1783.00 2167.50 -17.74 9005.40 9020.90 -0.17 9005.40 9020.90 -0.17
TAX 434.60 619.70 -29.87 1806.80 2264.50 -20.21 1806.80 2264.50 -20.21
Deferred Tax -34.90 -65.80 -46.96 95.10 97.70 -2.66 95.10 97.70 -2.66
PAT 1348.40 1547.80 -12.88 7198.60 6756.40 6.54 7198.60 6756.40 6.54
Equity 171.70 173.90 -1.27 171.70 173.90 -1.27 171.70 173.90 -1.27
PBIDTM(%) 28.16 33.21 -15.21 32.82 37.54 -12.58 32.82 37.54 -12.58
Peers
Company Name CMP
Sun Pharma. Inds. 1866.00
Dr. Reddys Labs. 1172.05
Cipla 1372.25
Lupin 2092.00
Zydus Lifesciences 1137.35
View more..